Trials / Completed
CompletedNCT01009554
Oral Tissue Tolerance of a Mouthrinse
Assessment of the Oral Tissue Tolerance of a Potassium Oxalate Containing Mouthrinse
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- Johnson & Johnson Consumer and Personal Products Worldwide · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is 8 weeks long. People participating in this study will be asked to brush their teeth two times a day. Some people will get a mouthwash. People with a mouthwash will rinse two times a day after brushing their teeth. The mouth, teeth, tongue and gums will be looked at by a dentist. The dentist will look at the mouth to make sure the mouthwash does not irritate the mouth. The dentist will also look at the color of the teeth and amount of stain on the front teeth.
Detailed description
This is an 8-week, randomized, observer-blind, controlled, parallel group clinical study design to assess the oral tissue tolerance of a potassium oxalate containing mouthrinse. Subjects will have their oral soft/hard tissues assessed and will be evaluated for stain levels and tooth color shades at Screening/Baseline (Visit 1), Week 4 (Visit 2), Week 6 (Visit 3) and Week 8 (Visit 4). Subjects will be instructed to brush their teeth two times daily in their usual manner using the provided sodium fluoride toothpaste. Subjects assigned to the mouthrinse group will be instructed to rinse twice daily after brushing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Potassium Oxylate Mouthwash | Rinse with 10 mL for 60 seconds, twice daily after brushing in usual manner with a sodium fluoride dentifrice |
| DRUG | Sodium Fluoride Dentifrice | Brush in usual manner, twice daily, with a sodium fluoride dentifrice |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2009-11-06
- Last updated
- 2015-07-03
- Results posted
- 2015-07-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01009554. Inclusion in this directory is not an endorsement.